Evidence map›Paper›PMID 27739124›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2016

Aducanumab reduces Aβ plaques in Alzheimer's disease.

David E Vaillancourt

Abstract readComment
PubMed Publisher
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Screening of [ACS pharmacology & translational science · 2024
    Article
  2. α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives.Movement disorders : official journal of the Movement Disorder Society · 2022
    Review
  3. Early active immunization with AβNeural regeneration research · 2020
    Article
  4. Efficacy and safety of anti-amyloid-Annals of clinical and translational neurology · 2017
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

David E VaillancourtDepartment of Applied Physiology and Kinesiology, Department of Neurology, and Department of Biomedical Engineering, University of Florida, Gainesville, FL, USA.

Funding

University of Florida - Mt. Sinai Medical Center AD Research CenterP50AG047266 · NIA · UNIVERSITY OF FLORIDA · PI FEBO, MARCELO · 2015 to 2019
$7.3M
Scaling and Sequencing Motor Output in Humans: fMRI StudyR01NS052318 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI VAILLANCOURT, DAVID E · 2005 to 2020
$6.0M
NIA NIH HHS P50 AG047266NINDS NIH HHS R01 NS052318
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer DiseasePlaque, AmyloidAmyloid beta-PeptidesAntibodies, Monoclonal, HumanizedHumansaducanumabAmyloid beta-PeptidesAntibodies, Monoclonal, Humanized

Identifiers

PMID27739124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.